GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Investor Meeting02-09-2020
02-09-2020
GRANULES INDIA LTD.-$ - 532482 - Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
The Exchange has received Disclosure under Regulation 31(1) and 31(2) of SEBI (Substantial Acquisition of Shares & Takeovers) Regulations, 2011 on September 02, 2020 for Krishna Prasad Chigurupati02-09-2020
Granules India rises 3% on USFDA nod to insomnia drug
The company now has a total of 29 ANDA approvals from USFDA (27 final approvals and 2 tentative approvals), Granules India said.24-08-2020
GRANULES INDIA LTD.-$ - 532482 - Granules Pharmaceuticals, Inc. Received US FDA Approval For Ramelteon Tablets, 8 Mg
Granules Pharmaceuticals, Inc. received US FDA approval for Ramelteon Tablets, 8 mg22-08-2020
GRANULES INDIA LTD.-$ - 532482 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Granules India Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here14-08-2020
GRANULES INDIA LTD.-$ - 532482 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Regulation 30 and Regulation 44(3) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations 2015- Proceeding and details of the voting results of the 29th Annual General Meeting14-08-2020
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Allotment
Allotment of 2,10,608 equity shares under ESOS 2009.11-08-2020
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Intimation of Schedule of the Investor Meeting07-08-2020
GRANULES INDIA LTD.-$ - 532482 - Announcement under Regulation 30 (LODR)-Press Release / Media Release
Granules Pharmaceuticals, Inc. issues clarification on media reports of recall of 4.78 lakh bottles of Metformin Hydrochloride Extended-Release(ER) tablets USP, 750mg27-07-2020
Lupin, Granules India recall around 9.71 lakh bottles of diabetes drug in the US market
As per the USFDA, the companies are recalling the product due to deviation from the current good manufacturing practices (CGMP).26-07-2020